Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy

Louise R. A. Olde Nordkamp, Reinoud E. Knops, Gust H. Bardy, Yuri Blaauw, Lucas V. A. Boersma, Johannes S. Bos, Peter Paul H. M. Delnoy, Pascal F. H. M. van Dessel, Antoine H. G. Driessen, Joris R. de Groot, Jean Paul R. Herrman, Luc J. L. M. Jordaens, Kirsten M. Kooiman, Alexander H. Maass, Mathias Meine, Yuka Mizusawa, Sander G. Molhoek, Jurjen van Opstal, Jan G. P. Tijssen, Arthur A. M. Wilde

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)753-+
JournalAmerican Heart Journal
Volume163
Issue number5
DOIs
Publication statusPublished - May 2012

Cite this

Nordkamp, L. R. A. O., Knops, R. E., Bardy, G. H., Blaauw, Y., Boersma, L. V. A., Bos, J. S., Delnoy, P. P. H. M., van Dessel, P. F. H. M., Driessen, A. H. G., de Groot, J. R., Herrman, J. P. R., Jordaens, L. J. L. M., Kooiman, K. M., Maass, A. H., Meine, M., Mizusawa, Y., Molhoek, S. G., van Opstal, J., Tijssen, J. G. P., & Wilde, A. A. M. (2012). Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. American Heart Journal, 163(5), 753-+. https://doi.org/10.1016/j.ahj.2012.02.012